{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:32:48Z","timestamp":1790130768048,"version":"4.0.1"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>Positron emission tomography combined with computed tomography (PET\/CT) has revolutionized radiation oncology by merging functional and anatomical imaging to enhance tumor characterization, guide treatment precision, and support individualized patient care. This review critically evaluates the clinical applications of PET\/CT-guided radiation therapy, highlighting its evolving impact, technical innovations, limitations, and future research directions. Key clinical uses \u2013 such as improved target delineation, adaptive therapy, and treatment response monitoring \u2013 are explored alongside the diagnostic performance of diverse radiotracers including 18F-fluorodeoxyglucose, prostate-specific membrane antigen-targeted agents, and hypoxia-specific probes. We examine advanced methodologies such as deformable image registration, radiomics, and artificial intelligence (AI)-driven segmentation for their potential to reduce interobserver variability and streamline radiotherapy (RT) workflows. The review also addresses persistent barriers, including limited tracer specificity, spatial resolution constraints, integration complexity, and high implementation costs. Beyond technical discussions, we reflect on emerging ethical considerations, such as transparency in AI-driven planning, patient consent in algorithm-assisted treatment decisions, and the need for equitable access to PET\/CT technologies. We emphasize the importance of interdisciplinary collaboration and standardized imaging protocols to optimize clinical adoption. With continuous innovation and global access initiatives, PET\/CT-guided RT is poised to play a leading role in shaping the future of precision oncology.<\/jats:p>","DOI":"10.4103\/jmp.jmp_34_25","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:01:33Z","timestamp":1751515293000},"page":"198-206","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Integrating Positron Emission Tomography Combined with Computed Tomography Imaging into Advanced Radiation Therapy Planning: Clinical Applications, Innovations, and Challenges"],"prefix":"10.4103","volume":"50","author":[{"given":"Subhash Chand","family":"Kheruka","sequence":"first","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Center, University Medical City, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Center, University Medical City, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Sharjeel","family":"Usmani","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Center, University Medical City, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naema","family":"Al-Maymani","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Center, University Medical City, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura","family":"Al-Makhmari","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Center, University Medical City, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda","family":"Al-Saidi","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Center, University Medical City, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Al-Rashdi","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Center, University Medical City, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Al-Balushi","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Center, University Medical City, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin","family":"Jayakrishnan","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Center, University Medical City, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khulood","family":"Al-Riyami","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Center, University Medical City, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashid","family":"Al-Sukaiti","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Center, University Medical City, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raza","family":"Sayani","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Sultan Qaboos Comprehensive Cancer Care and Research Center, University Medical City, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"R1-20250703","first-page":"18N","article-title":"A definition of molecular imaging","volume":"48","author":"Mankoff","year":"2007","journal-title":"J Nucl Med"},{"key":"R2-20250703","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.radonc.2008.11.008","article-title":"Use of PET and PET\/CT for radiation therapy planning: IAEA expert report 2006\u20132007","volume":"91","author":"MacManus","year":"2009","journal-title":"Radiother Oncol"},{"key":"R3-20250703","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0001-2998(96)80006-7","article-title":"Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose PET: Potential for error","volume":"26","author":"Cook","year":"1996","journal-title":"Semin Nucl Med"},{"key":"R4-20250703","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0360-3016(03)00346-8","article-title":"Radiation treatment planning with an integrated positron emission and computer tomography (PET\/CT): A feasibility study","volume":"57","author":"Ciernik","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-20250703","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijrobp.2006.12.029","article-title":"The impact of positron emission tomography\/computed tomography in edge delineation of gross tumor volume for head and neck cancers","volume":"68","author":"Ashamalla","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-20250703","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0360-3016(99)00061-9","article-title":"FDG-PET for planning radiotherapy in lung cancer: High impact in atelectasis","volume":"44","author":"Nestle","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-20250703","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/j.semnuclmed.2004.06.004","article-title":"Positron emission tomography for prostate, bladder, and renal cancer","volume":"34","author":"Sch\u00f6der","year":"2004","journal-title":"Semin Nucl Med"},{"key":"R8-20250703","first-page":"264","article-title":"PET radiopharmaceuticals for oncology","volume":"41","author":"Vallabhajosula","year":"2011","journal-title":"Semin Nucl Med"},{"key":"R9-20250703","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"R10-20250703","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc882","article-title":"Molecular imaging of cancer with positron emission tomography","volume":"2","author":"Gambhir","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"R11-20250703","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.semnuclmed.2003.12.003","article-title":"Pitfalls in FDG PET and PET\/CT oncologic imaging","volume":"34","author":"Cook","year":"2004","journal-title":"Semin Nucl Med"},{"key":"R12-20250703","first-page":"1225","article-title":"FDG uptake inversely correlated with colorectal cancer differentiation","volume":"45","author":"Ponde","year":"2004","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"R13-20250703","first-page":"87S","article-title":"Cancer imaging with FDG, DOPA, choline, and methionine","volume":"46","author":"Langsteger","year":"2005","journal-title":"J Nucl Med"},{"key":"R14-20250703","first-page":"732","article-title":"FDOPA-PET\/CT for glioblastoma recurrence detection","volume":"50","author":"Herrmann","year":"2009","journal-title":"J Nucl Med"},{"key":"R15-20250703","first-page":"1356","article-title":"Imaging malignant bone involvement","volume":"46","author":"Even-Sapir","year":"2005","journal-title":"J Nucl Med"},{"key":"R16-20250703","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2967\/jnumed.106.037200","article-title":"Skeletal PET with 18F-fluoride: Applying new technology to an old tracer","volume":"49","author":"Grant","year":"2008","journal-title":"J Nucl Med"},{"key":"R17-20250703","first-page":"210","article-title":"SNM guideline for sodium 18F-fluoride PET\/CT","volume":"38","author":"Segall","year":"2010","journal-title":"J Nucl Med Technol"},{"key":"R18-20250703","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00259-008-0788-z","article-title":"18F-choline versus 18F-fluoride for prostate cancer bone metastases","volume":"35","author":"Beheshti","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R19-20250703","first-page":"1393","article-title":"18F fluciclovine PET\/CT in recurrent prostate cancer","volume":"57","author":"Odewole","year":"2016","journal-title":"J Nucl Med"},{"key":"R20-20250703","first-page":"1259","article-title":"18F fluciclovine versus 18F FDG in prostate cancer","volume":"44","author":"Bach Gansmo","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R21-20250703","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.juro.2013.10.065","article-title":"FACBC PET CT versus capromab for recurrent prostate cancer","volume":"191","author":"Schuster","year":"2014","journal-title":"J Urol"},{"key":"R22-20250703","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1200\/JCO.2007.15.1126","article-title":"Staging carcinoid tumors with 18F DOPA","volume":"26","author":"Koopmans","year":"2008","journal-title":"J Clin Oncol"},{"key":"R23-20250703","first-page":"e156","article-title":"68Ga DOTATATE PET\/CT in neuroendocrine tumors","volume":"20","author":"Hofman","year":"2019","journal-title":"Lancet Oncol"},{"key":"R24-20250703","first-page":"1172","article-title":"The NETPET score for neuroendocrine tumors","volume":"61","author":"Strosberg","year":"2020","journal-title":"J Nucl Med"},{"key":"R25-20250703","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1158\/2159-8290.CD-14-0697","article-title":"18F FES in metastatic breast cancer","volume":"5","author":"van Kruchten","year":"2015","journal-title":"Cancer Discov"},{"key":"R26-20250703","doi-asserted-by":"crossref","first-page":"67S","DOI":"10.2967\/jnumed.116.186767","article-title":"Prostate-specific membrane antigen ligands for imaging and therapy","volume":"58","author":"Eiber","year":"2017","journal-title":"J Nucl Med"},{"key":"R27-20250703","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2967\/jnumed.118.209387","article-title":"Potential impact of (68)Ga-PSMA-11 PET\/CT on the planning of definitive radiation therapy for prostate cancer","volume":"59","author":"Calais","year":"2018","journal-title":"J Nucl Med"},{"key":"R28-20250703","first-page":"1175","article-title":"F-18 FAZA PET imaging of tumor hypoxia: Synthesis, evaluation and comparison with F-18 FMISO","volume":"52","author":"Rajendran","year":"2011","journal-title":"J Nucl Med"},{"key":"R29-20250703","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijrobp.2006.12.037","article-title":"Hypoxia imaging using 18F-FAZA PET and dose painting by numbers in head and neck cancer","volume":"68","author":"Thorwarth","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R30-20250703","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"(68)Ga-FAPI PET\/CT: Biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers","volume":"60","author":"Giesel","year":"2019","journal-title":"J Nucl Med"},{"key":"R31-20250703","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A tumor-imaging method targeting cancer-associated fibroblasts","volume":"59","author":"Loktev","year":"2018","journal-title":"J Nucl Med"},{"key":"R32-20250703","first-page":"687","article-title":"Clinical impact of PSMA-based PET imaging on radiation therapy planning in prostate cancer","volume":"46","author":"M\u00fcller","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R33-20250703","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00259-010-1423-3","article-title":"PET-guided delineation of radiation therapy treatment volumes: A survey of image segmentation techniques","volume":"37","author":"Zaidi","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R34-20250703","first-page":"5307","article-title":"Evaluation of deformable image registration methods for thoracic and head-and-neck CT imaging","volume":"44","author":"Yang","year":"2017","journal-title":"Med Phys"},{"key":"R35-20250703","first-page":"S99","article-title":"Image registration and data fusion in radiation therapy","volume":"1","author":"Kessler","journal-title":"Br J Radiol 2006;79 Spec No"},{"key":"R36-20250703","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"Image biomarker standardisation initiative","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"R37-20250703","first-page":"146","article-title":"Imaging-based target volume delineation in radiation oncology: A review","volume":"150","author":"Nestle","year":"2020","journal-title":"Radiother Oncol"},{"key":"R38-20250703","first-page":"13","article-title":"Big data and machine learning in radiation oncology: State of the art and future prospects","volume":"472","author":"Bibault","year":"2019","journal-title":"Cancer Lett"},{"key":"R39-20250703","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41824-020-00086-8","article-title":"Applications of artificial intelligence and deep learning in molecular imaging and radiotherapy","volume":"4","author":"Arabi","year":"2020","journal-title":"Eur J Hybrid Imaging"},{"key":"R40-20250703","first-page":"e504","article-title":"Ethical and regulatory perspectives for the use of artificial intelligence in radiation oncology","volume":"33","author":"Parisot","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R41-20250703","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1200\/EDBK_159036","article-title":"Risk-adapted treatment of advanced Hodgkin lymphoma with PET-CT","volume":"35","author":"Lynch","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"R42-20250703","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted treatment guided by interim PET-CT scan in advanced Hodgkin\u2019s lymphoma","volume":"374","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"key":"R43-20250703","doi-asserted-by":"crossref","first-page":"309237","DOI":"10.1155\/2011\/309237","article-title":"PET response-guided treatment of Hodgkin\u2019s lymphoma: A review of the evidence and active clinical trials","volume":"2011","author":"Aridgides","year":"2011","journal-title":"Adv Hematol"},{"key":"R44-20250703","first-page":"33","article-title":"Recommendations for the use of PET imaging in radiation therapy planning","volume":"149","author":"Gr\u00e9goire","year":"2020","journal-title":"Radiother Oncol"},{"key":"R45-20250703","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijrobp.2009.06.031","article-title":"Results of a multi-institution deformable registration accuracy study (MIDRAS)","volume":"76","author":"Brock","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R46-20250703","article-title":"Deep learning-based synthetic CT generation for MRI-only radiotherapy: Challenges and opportunities","volume":"17","author":"Maspero","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"key":"R47-20250703","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.semradonc.2014.02.008","article-title":"The ViewRay system: Magnetic resonance-guided and controlled radiotherapy","volume":"24","author":"Mutic","year":"2014","journal-title":"Semin Radiat Oncol"},{"key":"R48-20250703","first-page":"1369","article-title":"A combined PET\/CT scanner for clinical oncology","volume":"41","author":"Beyer","year":"2000","journal-title":"J Nucl Med"},{"key":"R50-20250703","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"68Ga-FAPI PET\/CT: Dosimetry","volume":"60","author":"Giesel","year":"2019","journal-title":"J Nucl Med"},{"key":"R51-20250703","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijrobp.2006.11.061","article-title":"Hypoxia dose painting by numbers: A planning study","volume":"68","author":"Thorwarth","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R52-20250703","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"Cancer-associated fibroblast imaging using FAP-specific PET tracer 68Ga-FAPI","volume":"59","author":"Loktev","year":"2018","journal-title":"J Nucl Med"},{"key":"R53-20250703","first-page":"e504","article-title":"Ethical perspectives on artificial intelligence in radiation oncology","volume":"33","author":"Parisot","year":"2021","journal-title":"Clin Oncol"},{"key":"R54-20250703","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted treatment guided by PET-CT in advanced Hodgkin\u2019s lymphoma","volume":"374","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"key":"R55-20250703","first-page":"725215","article-title":"PET and PET\/CT in esophageal and gastrointestinal tumors","volume":"2011","author":"Aridgides","year":"2011","journal-title":"Adv Hematol"},{"key":"R56-20250703","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0360-3016(99)00061-9","article-title":"Positron emission tomography for target volume definition in non-small cell lung cancer","volume":"44","author":"Nestle","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R57-20250703","first-page":"1407","article-title":"Integrating PET imaging into the management of brain tumors","volume":"50","author":"Herrmann","year":"2009","journal-title":"J Nucl Med"},{"key":"R58-20250703","first-page":"719","article-title":"Evaluation of hybrid 68Ga-PSMA ligand PET\/CT in primary prostate cancer","volume":"58","author":"Eiber","year":"2017","journal-title":"J Nucl Med"},{"key":"R59-20250703","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2967\/jnumed.118.209387","article-title":"Impact of 68Ga-PSMA-11 PET\/CT on the planning of definitive radiation therapy for prostate cancer","volume":"59","author":"Calais","year":"2018","journal-title":"J Nucl Med"},{"key":"R60-20250703","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijrobp.2006.12.037","article-title":"Hypoxia imaging for individual dose prescription in radiotherapy: The potential of PET","volume":"68","author":"Thorwarth","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R61-20250703","first-page":"33","article-title":"Recommendations for target volume definition in head and neck cancer with PET","volume":"149","author":"Gr\u00e9goire","year":"2020","journal-title":"Radiother Oncol"},{"key":"R62-20250703","first-page":"146","article-title":"EANM\/IAEA consensus guidelines for PET use in radiation therapy planning","volume":"150","author":"Gr\u00e9goire","year":"2020","journal-title":"Radiother Oncol"},{"key":"R63-20250703","first-page":"e504","article-title":"Artificial intelligence and ethics in oncology: Challenges and perspectives","volume":"33","author":"Parisot","year":"2021","journal-title":"Clin Oncol"}],"container-title":["Journal of Medical Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jmp.jmp_34_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:57:38Z","timestamp":1786647458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jmp.jmp_34_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jmp.jmp_34_25","relation":{},"ISSN":["0971-6203","1998-3913"],"issn-type":[{"value":"0971-6203","type":"print"},{"value":"1998-3913","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2025-02-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}